Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...
Nature is beautiful, powerful and essential. But nature is not always gentle. The same biological world that gives rise to ...
Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results